Collection
Digital Features - Dermatology
- Submission status
- Open
- Open for submission from
- 21 April 2021
- Submission deadline
- Ongoing
A collection of recent articles with digital features such as video abstracts published in the American Journal of Clinical Dermatology, Dermatology & Therapy and Advances in Therapy
Articles (78 in this collection)
-
-
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab (Interleukin-23p19 Inhibitor)
Authors (first, second and last of 9)
- Melinda Gooderham
- Ronald Vender
- Lawrence Green
- Content type: Original Research
- Open Access
- Published: 09 February 2024
- Dermatology and Therapy
- Pages: 441 - 451
-
Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis
Authors (first, second and last of 9)
- Hidehisa Saeki
- Yoko Kataoka
- Kazuhiko Arima
- Content type: Brief Report
- Open Access
- Published: 07 February 2024
- Dermatology and Therapy
- Pages: 533 - 543
-
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
Authors (first, second and last of 11)
- Amy S. Paller
- Andreas Pinter
- Mike Bastian
- Content type: Original Research
- Open Access
- Published: 09 January 2024
- Advances in Therapy
- Pages: 1046 - 1061
-
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
Authors (first, second and last of 6)
- Eric L. Simpson
- Ben Lockshin
- Andrew Korotzer
- Content type: Brief Report
- Open Access
- Published: 04 January 2024
- Dermatology and Therapy
- Pages: 261 - 270
-
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1
Authors (first, second and last of 8)
- Eric L. Simpson
- Andrew Blauvelt
- Andreas Wollenberg
- Content type: Original Research Article
- Open Access
- Published: 07 October 2023
- American Journal of Clinical Dermatology
- Pages: 139 - 148
-
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6–11 Years of Age with Severe Atopic Dermatitis
Authors (first, second and last of 11)
- Michael J. Cork
- Diamant Thaçi
- Noah A. Levit
- Content type: Original Research
- Open Access
- Published: 26 September 2023
- Dermatology and Therapy
- Pages: 2697 - 2719
-
Burden of Herpes Zoster Among Patients with Psoriasis in the United States
Authors (first, second and last of 11)
- David Singer
- Philippe Thompson-Leduc
- Sara Poston
- Content type: Original Research
- Open Access
- Published: 22 September 2023
- Dermatology and Therapy
- Pages: 2649 - 2668
-
Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Authors (first, second and last of 11)
- Diamant Thaçi
- Christos Tziotzios
- Ernest Law
- Content type: Original Research
- Open Access
- Published: 14 September 2023
- Dermatology and Therapy
- Pages: 2621 - 2634
-
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
Authors (first, second and last of 14)
- Eric L. Simpson
- Andrew E. Pink
- Andreas Wollenberg
- Content type: Original Research Article
- Open Access
- Published: 08 September 2023
- American Journal of Clinical Dermatology
- Pages: 939 - 952
-
Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
Authors (first, second and last of 7)
- April W. Armstrong
- Sang Hee Park
- Viktor Chirikov
- Content type: Original Research
- Open Access
- Published: 31 July 2023
- Dermatology and Therapy
- Pages: 2589 - 2603
-
Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors
Authors (first, second and last of 7)
- Lana Schmidt
- Ching An Wang
- Lauren Seigel
- Content type: Original Research
- Open Access
- Published: 30 July 2023
- Dermatology and Therapy
- Pages: 2019 - 2030
-
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
Authors (first, second and last of 6)
- Melinda J. Gooderham
- Andrew E. Pink
- Melissa Watkins
- Content type: Review
- Open Access
- Published: 23 July 2023
- Dermatology and Therapy
- Pages: 1893 - 1907
-
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Authors (first, second and last of 10)
- Elaine C. Siegfried
- Eric L. Simpson
- Ainara RodrÃguez Marco
- Content type: Original Research
- Open Access
- Published: 22 July 2023
- Dermatology and Therapy
- Pages: 1987 - 2000
-
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome
Authors (first, second and last of 10)
- Philip J. Mease
- Gülen Hatemi
- Linda Stein Gold
- Content type: Original Research Article
- Open Access
- Published: 14 June 2023
- American Journal of Clinical Dermatology
- Pages: 809 - 820
-
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial
Authors (first, second and last of 9)
- Elaine C. Siegfried
- Michael J. Cork
- Annie Zhang
- Content type: Original Research Article
- Open Access
- Published: 10 June 2023
- American Journal of Clinical Dermatology
- Pages: 787 - 798
-
Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
Authors (first, second and last of 8)
- Prethibha George
- Oladayo Jagun
- Samuel H. Zwillich
- Content type: Original Research
- Open Access
- Published: 10 June 2023
- Dermatology and Therapy
- Pages: 1733 - 1746
-
Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey
Authors (first, second and last of 7)
- Sydney Thai
- Sophie Barlow
- Jashin J. Wu
- Content type: Original Research
- Open Access
- Published: 31 May 2023
- Dermatology and Therapy
- Pages: 1289 - 1303
-
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Authors (first, second and last of 14)
- Linda Stein Gold
- Diamant Thaçi
- Marjolein de Bruin-Weller
- Content type: Original Research Article
- Open Access
- Published: 17 May 2023
- American Journal of Clinical Dermatology
- Pages: 595 - 607
-
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey
Authors (first, second and last of 8)
- Joseph F. Merola
- Alexis Ogdie
- Mark Lebwohl
- Content type: Original Research
- Open Access
- Published: 15 May 2023
- Dermatology and Therapy
- Pages: 1329 - 1346
-
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Authors (first, second and last of 11)
- Lawrence F. Eichenfield
- Richard G. Gower
- John Werth
- Content type: Original Research Article
- Open Access
- Published: 15 May 2023
- American Journal of Clinical Dermatology
- Pages: 623 - 635
-
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy
Authors (first, second and last of 14)
- Eftychia Chatziioannou
- Ulrike Leiter
- Teresa Amaral
- Content type: Original Research Article
- Open Access
- Published: 04 May 2023
- American Journal of Clinical Dermatology
- Pages: 453 - 467
-
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
Authors (first, second and last of 11)
- Ohsang Kwon
- Maryanne M. Senna
- Brett King
- Content type: Original Research Article
- Open Access
- Published: 01 March 2023
- American Journal of Clinical Dermatology
- Pages: 443 - 451
-
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
Authors (first, second and last of 12)
- Jonathan I. Silverberg
- Charles W. Lynde
- Noah A. Levit
- Content type: Original Research Article
- Open Access
- Published: 20 February 2023
- American Journal of Clinical Dermatology
- Pages: 469 - 483
-
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study
Authors (first, second and last of 12)
- Akihiko Asahina
- Yukari Okubo
- Hidemi Nakagawa
- Content type: Original Research
- Open Access
- Published: 17 January 2023
- Dermatology and Therapy
- Pages: 751 - 768
-
Novel Therapies in Plaque Psoriasis: A Review of Tyrosine Kinase 2 Inhibitors
Authors
- George Martin
- Content type: Review
- Open Access
- Published: 02 January 2023
- Dermatology and Therapy
- Pages: 417 - 435
-
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data
Authors (first, second and last of 12)
- Amit Garg
- Haley B. Naik
- Alexa B. Kimball
- Content type: Original Research
- Open Access
- Published: 31 December 2022
- Dermatology and Therapy
- Pages: 581 - 594
-
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
Authors (first, second and last of 12)
- Sonja Ständer
- Shawn G. Kwatra
- Claire Feeney
- Content type: Original Research Article
- Open Access
- Published: 13 December 2022
- American Journal of Clinical Dermatology
- Pages: 97 - 107
-
Economic Burden of Comorbidities in Patients with Psoriasis in the USA
Authors (first, second and last of 6)
- Jashin J. Wu
- Manasi Suryavanshi
- Lauren Seigel
- Content type: Original Research
- Open Access
- Published: 19 November 2022
- Dermatology and Therapy
- Pages: 207 - 219
-
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab
Authors (first, second and last of 10)
- Andrew Blauvelt
- Andreas Wollenberg
- Sonya L. Cyr
- Content type: Brief Report
- Open Access
- Published: 01 November 2022
- Advances in Therapy
- Pages: 367 - 380
-
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
Authors (first, second and last of 7)
- Jonathan I. Silverberg
- Mark Boguniewicz
- Noah A. Levit
- Content type: Original Research
- Open Access
- Published: 21 October 2022
- Dermatology and Therapy
- Pages: 2731 - 2746
-
Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis
Authors (first, second and last of 13)
- Amy S. Paller
- Gil Yosipovitch
- Dimittri Delevry
- Content type: Brief Report
- Open Access
- Published: 21 October 2022
- Dermatology and Therapy
- Pages: 2839 - 2850
-
Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis
Authors (first, second and last of 5)
- April Armstrong
- Qian Xia
- Lauren Seigel
- Content type: Original Research
- Open Access
- Published: 10 August 2022
- Dermatology and Therapy
- Pages: 2087 - 2103
-
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
Authors (first, second and last of 12)
- Jonathan I. Silverberg
- David N. Adam
- Stephan Weidinger
- Content type: Original Research Article
- Open Access
- Published: 20 July 2022
- American Journal of Clinical Dermatology
- Pages: 547 - 559
-
Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults
Authors (first, second and last of 8)
- Lida Teng
- Akiko Mizukami
- Taizo Matsuki
- Content type: Original Research
- Open Access
- Published: 06 June 2022
- Dermatology and Therapy
- Pages: 1447 - 1467
-
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis
Authors (first, second and last of 6)
- El-Bdaoui Haddad
- Sonya L. Cyr
- Frank O. Nestle
- Content type: Review
- Open Access
- Published: 21 May 2022
- Dermatology and Therapy
- Pages: 1501 - 1533
-
Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE)
Authors (first, second and last of 14)
- Jerry Bagel
- Tien Q. Nguyen
- Marius Ardeleanu
- Content type: Original Research
- Open Access
- Published: 20 May 2022
- Dermatology and Therapy
- Pages: 1417 - 1430
-
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Authors (first, second and last of 16)
- Andrew Blauvelt
- Emma Guttman-Yassky
- Ashish Bansal
- Content type: Original Research Article
- Open Access
- Published: 14 May 2022
- American Journal of Clinical Dermatology
- Pages: 365 - 383
-
Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation
Authors (first, second and last of 9)
- Lance Cowey
- Chieh-I. Chen
- Jessica J. Jalbert
- Content type: Original Research
- Open Access
- Published: 04 May 2022
- Dermatology and Therapy
- Pages: 1211 - 1224
-
Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
Authors (first, second and last of 14)
- Lisa A. Beck
- Mette Deleuran
- Arsalan Shabbir
- Content type: Original Research Article
- Open Access
- Published: 03 May 2022
- American Journal of Clinical Dermatology
- Pages: 393 - 408
-
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Authors (first, second and last of 8)
- Sanjay Chabra
- B. J. Gill
- Luis Puig
- Content type: Original Research
- Open Access
- Published: 21 April 2022
- Advances in Therapy
- Pages: 2862 - 2872
-
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
Authors (first, second and last of 8)
- Craig L. Leonardi
- Kyoungah See
- Richard B. Warren
- Content type: Original Research
- Open Access
- Published: 22 March 2022
- Advances in Therapy
- Pages: 2256 - 2269
-
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study
Authors (first, second and last of 10)
- Andrew Alexis
- Marjolein de Bruin-Weller
- Natalie Yin
- Content type: Original Research
- Open Access
- Published: 17 March 2022
- Dermatology and Therapy
- Pages: 771 - 785
-
Pathophysiology of Generalized Pustular Psoriasis
Authors
- Slaheddine Marrakchi
- Lluis Puig
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 13 - 19
-
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey
Authors (first, second and last of 6)
- Dale V. Reisner
- Frida Dunger Johnsson
- Kilian Eyerich
- Content type: Original Research Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 65 - 71
-
The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis
Authors
- Min Zheng
- Denis Jullien
- Kilian Eyerich
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 5 - 12
-
Clinical Disease Measures in Generalized Pustular Psoriasis
Authors (first, second and last of 5)
- A. David Burden
- Siew Eng Choon
- Richard B. Warren
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 39 - 50
-
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
Authors
- James Krueger
- LluÃs Puig
- Diamant Thaçi
- Content type: Review Article
- Open Access
- Published: 21 January 2022
- American Journal of Clinical Dermatology
- Pages: 51 - 64
-
Consistency of Response to Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis Over 1 Year
Authors (first, second and last of 6)
- Andrew Blauvelt
- Marjolein de Bruin-Weller
- Ana B. Rossi
- Content type: Commentary
- Open Access
- Published: 07 January 2022
- Dermatology and Therapy
- Pages: 9 - 13
-
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
Authors (first, second and last of 11)
- Kim A. Papp
- Melinda J. Gooderham
- Ronald B. Vender
- Content type: Study Protocol
- Open Access
- Published: 22 December 2021
- Dermatology and Therapy
- Pages: 253 - 265